These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 483251)

  • 41. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
    Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
    Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
    Colucci M; Paramo JA; Stassen JM; Collen D
    J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of urokinase-induced thrombolysis in a biphasic in vitro system.
    Iga Y; Stella SR; Chandler AB
    Haemostasis; 1985; 15(3):189-97. PubMed ID: 4029755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A role of fibrin deposits in the development of rabbit Masugi nephritis and effect of urokinase on the experimental glomerulonephritis (author's transl)].
    Akiba T; Tanaka K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):125-38. PubMed ID: 7047822
    [No Abstract]   [Full Text] [Related]  

  • 47. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
    Brochier M; Griguer P
    Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
    [No Abstract]   [Full Text] [Related]  

  • 48. Threshold phenomena in blood fibrinolysis.
    Matsuo O; Mihara H
    Thromb Res; 1977 May; 10(5):753-8. PubMed ID: 882961
    [No Abstract]   [Full Text] [Related]  

  • 49. [A study of urokinase lysis time in patients with various renal diseases].
    Shimizu K; Kishi T; Ootaka M; Yamamoto J; Shibata M; Ban I; Sakai H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1233-41. PubMed ID: 6762457
    [No Abstract]   [Full Text] [Related]  

  • 50. [Various aspects of the platelets-urokinase interaction].
    Bastida E; Villaverde CA; Borruel MT; Valdecasas FG
    Arch Farmacol Toxicol; 1979 Dec; 5(3):270-1. PubMed ID: 397805
    [No Abstract]   [Full Text] [Related]  

  • 51. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
    Matsuo O; Kawaguchi T; Kosugi T; Mihara H
    Thromb Res; 1978 Dec; 13(6):1125-30. PubMed ID: 749265
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase.
    Rampling MW
    Thromb Res; 1978 Feb; 12(2):287-95. PubMed ID: 635844
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibitory effect of decidua on fibrinolysis induced by urokinase and by the fibrinolytic activity of the rat ovum.
    Liedholm P; Astedt B
    Acta Obstet Gynecol Scand; 1976; 55(3):217-9. PubMed ID: 936985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study of different urokinase preparations.
    Millar WT; Smith JF
    Thromb Res; 1983 Jun; 30(5):425-9. PubMed ID: 6351343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of fibrinolysis in the vitreous body.
    Pandolfi M
    Bibl Anat; 1979; (18):292-7. PubMed ID: 159041
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of thrombolytic treatment on natural inhibitors of coagulation-fibrinolysis, with report of pulmonary embolic cases.
    Hasegawa H; Nagata H; Murakoshi T; Yamauchi M; Oguma Y; Kamishima K; Murao M
    Nihon Ketsueki Gakkai Zasshi; 1979 Feb; 42(1):79-83. PubMed ID: 425795
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugate.
    Bode C; Runge MS; Newell JB; Matsueda GR; Haber E
    J Mol Cell Cardiol; 1987 Apr; 19(4):335-41. PubMed ID: 3612817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of saruplase with acetylsalicylic acid, heparin, glyceryl trinitrate, tranexamic acid and aprotinin in a rabbit pulmonary thrombosis model.
    Schneider J
    Arzneimittelforschung; 1990 Oct; 40(10):1180-4. PubMed ID: 1705427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study of thrombolysis by high and low molecular weight urokinase in an in vitro perfusion system.
    Greenwald SR; Chandler AB
    Thromb Res; 1983 Sep; 31(6):799-806. PubMed ID: 6228033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thrombolysis using urokinase in acute phlebothrombosis].
    Minar E; Ehringer H; Marosi L; Sommer G; Deutsch E
    Vasa; 1984; 13(1):41-6. PubMed ID: 6702280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.